Health Care: Drugs

Vanda Pharmaceuticals Inc (VNDA: NASDAQ)

$10.71 -0.35 | -3.16%
03/05/15 - 04:00 PM ET
Company Profile
Price and Volume
Recent Price 11.06
52 Week High 19.25
52 Week Low 8.34
Avg. Daily Vol. (Mil) 0.82
Beta (3 year) 2.30
Share Related Items
Mkt Cap (Mil) 374.95
Shares Out (Mil) 33.90
Float (Mil) 25.84
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 1.50
Current Ratio 1.70
LT Debt/ Equity 0.00
Total Debt / Equity 0.00
Valuation Ratios
Price Earnings 20.10
Price/Sales 7.48
Price/Book 352.72
Price/Cash Flow -6.90
Per Share Data
Earnings 0.55
Sales 1.48
Book Value 0.03
Cash Flow -1.60
Business Summary
Vanda Pharmaceuticals, Inc. is a biopharmaceutical company engaged in the development and commercialization of products for the treatment of central nervous system disorders such as HETLIOZ, Fanapt and VLY-686.
General Information
2200 Pennsylvania Avenue NW
Suite 300 E
Washington, DC 20037
Industry : Drugs
Sector: Health Care
Employees: 60
CEO: Dr. Mihael Hristos Polym
Short Interest
Current Month (Mil) 8.68
Previous Month (Mil) 9.01
Short Interest Ratio (Days) 13.30
Management Effectiveness
Return on Equity n.a.
Return on Assets -72.20
Return on Investments -5,377.00
Gross Margin 99.50
EBIT Margin n.a.
Profit Margin 40.20

Portfolios with VNDA

Latest VNDA Headlines from TheStreet

More Financial News for VNDA

Press Releases for VNDA

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter